Skip to the main content

dsm-firmenich Ventures

Founded 2001 Website LinkedIn
Cheque Size$500K to $5M
Stages3
Industries15
Markets20
Stated Portfolio1
Operating Since2001 (25y)

About dsm-firmenich Ventures

dsm-firmenich Ventures is the corporate venture capital arm of dsm-firmenich, focusing on funding, coaching, and supporting innovative startups that drive transformation in nutrition, health, and beauty. Since its inception in 2001, it has invested in over 100 startups across various industries and sectors, aligning with dsm-firmenich's purpose of bringing progress to life. The venture capital philosophy emphasizes both commercial success and delivering meaningful positive impact for people and the planet. The investment strategy targets early-stage and growth-stage companies, typically investing between €500,000 and €5 million, with additional capital reserved for follow-on investments. dsm-firmenich Ventures seeks minority ownership stakes, usually between 5–25%, and prefers to syndicate deals to ensure sufficient working capacity for future rounds. The focus is on startups that align with the innovation ambitions of dsm-firmenich's business units: Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. Beyond financial investment, dsm-firmenich Ventures offers strategic collaboration, often serving as advisors and board members to the startups it invests in. This approach leverages the scientific, technological, and commercial resources of dsm-firmenich to foster fruitful collaboration and bring progress to life. The venture capital arm is active in North America and Europe, engaging with and investing in ambitious, promising startups that have the potential to accelerate innovation and make a significant impact in their respective sectors.

Geographical Focus

African markets1

Other stated markets19

United StatesUnited KingdomCanadaGermanyJapanAustraliaChinaIndiaBrazilFranceItalyUnited Arab EmiratesSwitzerlandSpainMexicoSouth KoreaNetherlandsRussiaBelgium

Requirements

Alignment with dsm-firmenich's business units, Potential for innovation and impact, Early-stage or growth-stage companies, Minority ownership stake (5–25%), Ability to collaborate strategically

Stated Portfolio1

Athian

As reported by the investor. We hold no profile for this company, so it is printed as stated rather than linked.